Cowin China Growth Fund II Trims Stake in INNOGEN-B With HK$3.73 Million Share Sale

Stock News

Aug 21

Hong Kong stock exchange filings reveal that on August 20, Cowin China Growth Fund II, L.P. reduced its holdings in INNOGEN-B (02591) by 860,000 shares, with each share priced at HK$4.3373, bringing the total transaction value to approximately HK$3.73 million.

Following the reduction, the fund's latest share count stands at around 24.1564 million shares, representing a 5.75% stake in the company. The filing also lists related entities, including Cowin Capital Investment III Limited, Cowin Capital Investment II LTD, and Cowin Capital Investment Limited.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1177536252"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1177536252\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1177536252?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-21 20:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1177536252","market":"sh","top_or_hot":-1,"title":"Cowin China Growth Fund II Trims Stake in INNOGEN-B With HK$3.73 Million Share Sale","media":"Stock News","content":"<p>Hong Kong stock exchange filings reveal that on August 20, <b>Cowin China Growth Fund II, L.P.</b> reduced its holdings in <b>INNOGEN-B (02591)</b> by 860,000 shares, with each share priced at HK$4.3373, bringing the total transaction value to approximately HK$3.73 million.<br><br>Following the reduction, the fund's latest share count stands at around 24.1564 million shares, representing a 5.75% stake in the company. The filing also lists related entities, including <b>Cowin Capital Investment III Limited</b>, <b>Cowin Capital Investment II LTD</b>, and <b>Cowin Capital Investment Limited</b>.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cowin China Growth Fund II Trims Stake in INNOGEN-B With HK$3.73 Million Share Sale</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCowin China Growth Fund II Trims Stake in INNOGEN-B With HK$3.73 Million Share Sale\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-08-21 20:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hong Kong stock exchange filings reveal that on August 20, <b>Cowin China Growth Fund II, L.P.</b> reduced its holdings in <b>INNOGEN-B (02591)</b> by 860,000 shares, with each share priced at HK$4.3373, bringing the total transaction value to approximately HK$3.73 million.<br><br>Following the reduction, the fund's latest share count stands at around 24.1564 million shares, representing a 5.75% stake in the company. The filing also lists related entities, including <b>Cowin Capital Investment III Limited</b>, <b>Cowin Capital Investment II LTD</b>, and <b>Cowin Capital Investment Limited</b>.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"","article_id":"1177536252","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1177536252","pubTimestamp":1787313643,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Hong Kong stock exchange filings reveal that on August 20, Cowin China Growth Fund II, L.P. reduced its holdings in INNOGEN-B (02591) by 860,000 shares, with each share priced at HK$4.3373, bringing...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1161":"生物科技","02591":"银诺医药-B","EWH":"香港ETF-iShares MSCI"},"translate_title":"Cowin China Growth Fund II 以 373 万港元出售股份减持 INNOGEN-B 股份","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02591":1,"EWH":1},"content_text":"Hong Kong stock exchange filings reveal that on August 20, Cowin China Growth Fund II, L.P. reduced its holdings in INNOGEN-B (02591) by 860,000 shares, with each share priced at HK$4.3373, bringing the total transaction value to approximately HK$3.73 million.Following the reduction, the fund's latest share count stands at around 24.1564 million shares, representing a 5.75% stake in the company. The filing also lists related entities, including Cowin Capital Investment III Limited, Cowin Capital Investment II LTD, and Cowin Capital Investment Limited.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}